Know Cancer

or
forgot password
  • cancer clinical trials in la porte, IN

  • Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lymphoma
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Colorectal Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Lung Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Recurrent Endometrial Carcinoma
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Lymphoma
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Michiana Hematology Oncology PC - La Porte
    La Porte, Indiana 46350
    Endometrial Cancer, Fatigue, Neurotoxicity
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    Michiana Hematology Oncology PC - La Porte
    La Porte, Indiana 46350
    Lung Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Atypical Endocervical Glandular Cell of Undetermined Significance, Atypical Endometrial Hyperplasia, Atypical Glandular Cell of Undetermined Significance, Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Carcinoma of Unknown Primary
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Lung Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Michiana Hematology Oncology PC - La Porte
    La Porte, Indiana 46350
    Ovarian Cancer, Sarcoma
    Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer, Hot Flashes, Menopausal Symptoms, Unspecified Adult Solid Tumor, Protocol Specific
    Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Psychosocial Effects of Cancer and Its Treatment
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Brain and Central Nervous System Tumors, Neurotoxicity
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Breast Cancer, Cardiac Toxicity
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer